Literature DB >> 17017521

Iron and Friedreich ataxia.

M Pandolfo1.   

Abstract

Friedreich ataxia is due to insufficient levels of frataxin, a mitochondrial iron chaperone that shields this metal from reactive oxygen species (ROS) and renders it bioavailable as Fe II. Frataxin participates in the synthesis of iron-sulfur clusters (ISCs), cofactors of several enzymes, including mitochondrial and cytosolic aconitase, complexes I, II and III of the respiratory chain, and ferrochelatase. It also plays a role in the maintenance of ISCs, in particular for mitochondrial aconitase. A role of frataxin in heme synthesis has been postulated, but is controversial. Insufficient frataxin leads to deficit of ISC enzymes and energy deficit. Iron levels increase in mitochondria. Oxidative stress may result from respiratory chain dysfunction and from direct reaction between iron and ROS. Stress pathways are activated that may lead to apoptosis or other forms of cell death. The basis for the selective vulnerability of specific neurons, like sensory neurons, is still unknown.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017521     DOI: 10.1007/978-3-211-45295-0_22

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  18 in total

Review 1.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

2.  The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.

Authors:  R Mark Payne
Journal:  Prog Pediatr Cardiol       Date:  2011-05

Review 3.  Cardiac involvement in hereditary ataxias.

Authors:  Sean Moore; Subha V Raman
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

4.  Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia.

Authors:  D L Ouellet; K Cherif; J Rousseau; J P Tremblay
Journal:  Gene Ther       Date:  2016-12-26       Impact factor: 5.250

Review 5.  Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.

Authors:  Rachael A Vaubel; Grazia Isaya
Journal:  Mol Cell Neurosci       Date:  2012-08-11       Impact factor: 4.314

Review 6.  Unanswered questions in Friedreich ataxia.

Authors:  David R Lynch; Eric C Deutsch; Robert B Wilson; Gihan Tennekoon
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

7.  Mitochondrial iron accumulation with age and functional consequences.

Authors:  Arnold Y Seo; Jinze Xu; Stephane Servais; Tim Hofer; Emanuele Marzetti; Stephanie E Wohlgemuth; Mitchell D Knutson; Hae Young Chung; Christiaan Leeuwenburgh
Journal:  Aging Cell       Date:  2008-10       Impact factor: 9.304

Review 8.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

9.  A cytosolic iron chaperone that delivers iron to ferritin.

Authors:  Haifeng Shi; Krisztina Z Bencze; Timothy L Stemmler; Caroline C Philpott
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

Review 10.  Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.

Authors:  Daniele Marmolino; Fabio Acquaviva
Journal:  Cerebellum       Date:  2009-01-23       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.